248 related articles for article (PubMed ID: 35048267)
1. Leptomeningeal metastases: the future is now.
Lukas RV; Thakkar JP; Cristofanilli M; Chandra S; Sosman JA; Patel JD; Kumthekar P; Stupp R; Lesniak MS
J Neurooncol; 2022 Feb; 156(3):443-452. PubMed ID: 35048267
[TBL] [Abstract][Full Text] [Related]
2. Treatment of leptomeningeal carcinomatosis: current challenges and future opportunities.
Kak M; Nanda R; Ramsdale EE; Lukas RV
J Clin Neurosci; 2015 Apr; 22(4):632-7. PubMed ID: 25677875
[TBL] [Abstract][Full Text] [Related]
3. Leptomeningeal metastasis from solid tumors.
Thakkar JP; Kumthekar P; Dixit KS; Stupp R; Lukas RV
J Neurol Sci; 2020 Apr; 411():116706. PubMed ID: 32007755
[TBL] [Abstract][Full Text] [Related]
4. Management of leptomeningeal metastasis in breast cancer.
Assi HI; Mahmoud T; Saadeh FS; El Darsa H
Clin Neurol Neurosurg; 2018 Sep; 172():151-159. PubMed ID: 30015053
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis and treatment patterns for patients with leptomeningeal metastasis from solid tumors across Europe.
Le Rhun E; Rudà R; Devos P; Hoang-Xuan K; Brandsma D; Pérez Segura P; Soffietti R; Weller M
J Neurooncol; 2017 Jun; 133(2):419-427. PubMed ID: 28455788
[TBL] [Abstract][Full Text] [Related]
6. Quantitative assessment of circulating tumor cells in cerebrospinal fluid as a clinical tool to predict survival in leptomeningeal metastases.
Diaz M; Singh P; Kotchetkov IS; Skakodub A; Meng A; Tamer C; Young RJ; Reiner AS; Panageas KS; Ramanathan LV; Pentsova E
J Neurooncol; 2022 Mar; 157(1):81-90. PubMed ID: 35113288
[TBL] [Abstract][Full Text] [Related]
7. Novel methods to diagnose leptomeningeal metastases in breast cancer.
Angus L; Martens JWM; van den Bent MJ; Sillevis Smitt PAE; Sleijfer S; Jager A
Neuro Oncol; 2019 Mar; 21(4):428-439. PubMed ID: 30418595
[TBL] [Abstract][Full Text] [Related]
8. Leptomeningeal Metastasis from Non-Small Cell Lung Cancer and Current Landscape of Treatments.
Ozcan G; Singh M; Vredenburgh JJ
Clin Cancer Res; 2023 Jan; 29(1):11-29. PubMed ID: 35972437
[TBL] [Abstract][Full Text] [Related]
9. Intrathecal synthesis of tumor markers is a highly sensitive test in the diagnosis of leptomeningeal metastasis from solid cancers.
Corsini E; Bernardi G; Gaviani P; Silvani A; de Grazia U; Ciusani E; Croci D; Salmaggi A
Clin Chem Lab Med; 2009; 47(7):874-9. PubMed ID: 19453289
[TBL] [Abstract][Full Text] [Related]
10. A retrospective, quantitative assessment of disease burden in patients with leptomeningeal metastases from non-small-cell lung cancer.
Nevel KS; DiStefano N; Lin X; Skakodub A; Ogilvie SQ; Reiner AS; Pentsova E; Boire A
Neuro Oncol; 2020 May; 22(5):675-683. PubMed ID: 32352148
[TBL] [Abstract][Full Text] [Related]
11. Single-cell RNA sequencing reveals the characteristics of cerebrospinal fluid tumour environment in breast cancer and lung cancer leptomeningeal metastases.
Ruan H; Wang Z; Sun Z; Wei J; Zhang L; Ju H; Wang T; Zhang C; Guan M; Pan S
Clin Transl Med; 2022 Jun; 12(6):e885. PubMed ID: 35678121
[TBL] [Abstract][Full Text] [Related]
12. [Auxiliary Diagnostic Value of Tumor Markers in the Cerebrospinal Fluid and Blood for Leptomeningeal Metastasis from Non-small Cell Lung Cancer].
Lin Y; Li H; Huang M; Yin Z; Wu J
Zhongguo Fei Ai Za Zhi; 2020 Jun; 23(6):516-525. PubMed ID: 32517459
[TBL] [Abstract][Full Text] [Related]
13. Cerebrospinal fluid circulating tumor cells as a quantifiable measurement of leptomeningeal metastases in patients with HER2 positive cancer.
Malani R; Fleisher M; Kumthekar P; Lin X; Omuro A; Groves MD; Lin NU; Melisko M; Lassman AB; Jeyapalan S; Seidman A; Skakodub A; Boire A; DeAngelis LM; Rosenblum M; Raizer J; Pentsova E
J Neurooncol; 2020 Jul; 148(3):599-606. PubMed ID: 32506369
[TBL] [Abstract][Full Text] [Related]
14. Novel approaches to treating leptomeningeal metastases.
Grewal J; Saria MG; Kesari S
J Neurooncol; 2012 Jan; 106(2):225-34. PubMed ID: 21874597
[TBL] [Abstract][Full Text] [Related]
15. Different next-generation sequencing pipelines based detection of tumor DNA in cerebrospinal fluid of lung adenocarcinoma cancer patients with leptomeningeal metastases.
Ge M; Zhan Q; Zhang Z; Ji X; Zhou X; Huang R; Liang X
BMC Cancer; 2019 Feb; 19(1):143. PubMed ID: 30755180
[TBL] [Abstract][Full Text] [Related]
16. EpCAM-based flow cytometry in cerebrospinal fluid greatly improves diagnostic accuracy of leptomeningeal metastases from epithelial tumors.
Milojkovic Kerklaan B; Pluim D; Bol M; Hofland I; Westerga J; van Tinteren H; Beijnen JH; Boogerd W; Schellens JH; Brandsma D
Neuro Oncol; 2016 Jun; 18(6):855-62. PubMed ID: 26566655
[TBL] [Abstract][Full Text] [Related]
17. Leptomeningeal Metastasis: A Review of the Pathophysiology, Diagnostic Methodology, and Therapeutic Landscape.
Nguyen A; Nguyen A; Dada OT; Desai PD; Ricci JC; Godbole NB; Pierre K; Lucke-Wold B
Curr Oncol; 2023 Jun; 30(6):5906-5931. PubMed ID: 37366925
[TBL] [Abstract][Full Text] [Related]
18. Detection of Aneuploidy in Cerebrospinal Fluid from Patients with Breast Cancer Can Improve Diagnosis of Leptomeningeal Metastases.
Angus L; Deger T; Jager A; Martens JWM; de Weerd V; van Heuvel I; van den Bent MJ; Sillevis Smitt PAE; Kros JM; Bindels EMJ; Heitzer E; Sleijfer S; Jongen JLM; Wilting SM
Clin Cancer Res; 2021 May; 27(10):2798-2806. PubMed ID: 33514525
[TBL] [Abstract][Full Text] [Related]
19. Cerebrospinal fluid-administered therapies for leptomeningeal metastases from solid tumors.
Baskaran AB; Bhatia A; Kumthekar P; Boire A; Lukas RV
Future Oncol; 2023 Aug; 19(26):1801-1807. PubMed ID: 37737023
[TBL] [Abstract][Full Text] [Related]
20. SHP-1 promoter 2 methylation in cerebrospinal fluid for diagnosis of leptomeningeal epithelial-derived malignancy (carcinomatous meningitis).
Vinayanuwattikun C; Mingmalairak S; Jittapiromsak N; Thaipisuttikul I; Sriuranpong V; Mutirangura A; Shuangshoti S
J Neurooncol; 2016 Sep; 129(3):395-403. PubMed ID: 27401153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
